Basu Anirban, Meltzer David
Section of General Internal Medicine, Department of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 2007, Office B201, Chicago, IL 60637, USA.
J Health Econ. 2005 Jul;24(4):751-73. doi: 10.1016/j.jhealeco.2004.12.002. Epub 2005 Apr 22.
Medical cost-effectiveness analyses traditionally treat patients as isolated individuals and neglect the effects of improvement in patients' health on the welfare of their family members. We use a model based on a family utility function with altruistic linkages to show that there can be direct and indirect effects on the welfare of all family members. We focus specially on a model of how the spillover effects to the spouse in a two-person family might affect choice of treatments for prostate cancer. We then test the predictions of this model by analyzing treatment choices of prostate cancer patients using the linked SEER-Medicare database. We find that our results are consistent with the model's predictions. We conclude that cost-effectiveness analyses may better reflect the full costs and benefits of medical interventions if they incorporate these family effects. However, concerns about equity present a dilemma for the practice of CEA from the societal perspective.
传统的医疗成本效益分析将患者视为孤立的个体,而忽视了患者健康改善对其家庭成员福利的影响。我们使用一个基于具有利他联系的家庭效用函数的模型来表明,这可能会对所有家庭成员的福利产生直接和间接影响。我们特别关注两人家庭中对配偶的溢出效应如何影响前列腺癌治疗选择的模型。然后,我们通过使用链接的监测、流行病学和最终结果(SEER)-医疗保险数据库分析前列腺癌患者的治疗选择来检验该模型的预测。我们发现我们的结果与模型的预测一致。我们得出结论,如果成本效益分析纳入这些家庭影响,可能会更好地反映医疗干预的全部成本和收益。然而,从社会角度来看,对公平性的担忧给成本效益分析的实践带来了困境。